Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SNX11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC100996740 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
JADE2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C19orf12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SP140L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYH14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM38 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC1A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDUFA9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANXA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC103091866 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LDOC1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GDPD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HOXB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WARS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on